Connect with us

Business

Aphria Inc (OTCMKTS:APHQF) is Going to the Show

Published

on

Precisely as we predicted here a month ago, Aphria Inc (OTCMKTS:APHQF) is set to move to the big board. The company just announced that its common shares have been approved for listing on the New York Stock Exchange and will commence trading effective the open of markets on November 2, 2018. While the TLRY bubble continues to implode, taking other far more credible stocks down with it, APHQF is likely a good line item on a cannabis investor shopping list into the shunning action.

According to the release, “Aphria’s shares will trade on the NYSE under ticker symbol “APHA”. The Company’s ticker symbol on the Toronto Stock Exchange (TSX) will also change from “APH” to “APHA”, effective November 2, 2018. Existing shares of Aphria, which previously traded on the OTCQB under the ticker symbol “APHQF” will now trade on the NYSE.”

Aphria Inc (OTCMKTS:APHQF) commands a market cap of $3.46B as a leading global cannabis company driven by “an unrelenting commitment to our people, product quality and innovation.”

Headquartered in Leamington, Ontario – the greenhouse capital of Canada – Aphria has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities and backed by the latest technologies, Aphria is committed to bringing breakthrough innovation to the global cannabis market.

The Company’s portfolio of brands is grounded in expertly-researched consumer insights designed to meet the needs of every consumer segment. “Rooted in our founders’ multi-generational expertise in commercial agriculture, Aphria drives sustainable long-term shareholder value through a diversified approach to innovation, strategic partnerships and global expansion, with a presence in more than 10 countries across 5 continents.”

The company touts itself as one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. The company is truly powered by sunlight, allowing for the most natural growing conditions available. “We are committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. We are the first public licensed producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters.”

 

Movin’ On Up

As we discussed earlier, APHQF just announced is set to move to the big board. The company just announced that its common shares have been approved for listing on the New York Stock Exchange and will commence trading effective the open of markets on November 2, 2018.

This news, while obviously helpful, figures into a tape that has been defined by distribution of late, with shares of APHQF taking a hit in recent action, down about -17% over the past week. It should be an interesting battle in terms of how the stock reacts in coming days.

“Listing on the NYSE provides Aphria with access to the largest equity market in the world, with increased exposure to a vast array of US institutional and retail investors. This strategic move aligns directly with our growth ambitions as we enter an elite peer group of respected, high-profile corporate brands listed on the NYSE,” said Vic Neufeld, Aphria CEO.

Aphria Inc (OTCMKTS:APHQF) managed to rope in revenues totaling $13.3M in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top line growth of 117.2%, as compared to year-ago data in comparable terms. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($314M against $54.9M).

Business

Green Organic Dutchman Holdings (OTCMKTS:TGODF) To Review Financing Alternatives For Construction Purposes

Published

on

Green Organic Dutchman Holdings (OTCMKTS:TGODF) has, over the years, been focusing on the production of premium organic cannabis products. The business guru has today disclosed details about its credit financing. According to its spokesperson, the company needs to complete the construction of a number of its business facilities. The facilities are in Ontario, Ancaster, and Phase 1a at Valleyfield, Quebec. Lately, the business has been reviewing some financial alternatives to see the ones to settle for.

The turn of events

In a statement, the company has revealed that the market conditions have been very dynamic and thus need from proper planning. It has, in the past, held discussions regarding some commercial bank facilities and equipment leasing in a bid to identify what would work. The company admits that the discussions were fruitful since it was able to chart the way forward. However, the main point of the discussion wasn’t arrived at. That was because most of the financing sources turned out to be inappropriate. The company says that most of them did not match the required timeframes. It says it had no otherwise but to start reviewing other alternatives.

Plans moving forward

The completion of these facilities is a costly undertaking, but the company seems quite determined.

An official working with The Green Organic Dutchman Holdings but who wanted his identity kept anonymous has made a point. He says that the company, at the moment, has no debt. However, it has about $56.7 million available in cash in Canada. It also has some $40.2 million that will take care of the company’s capital expenditures. The construction activities at the Ancaster are almost reaching completion according to sources. The business giant says that in a matter of about 6-weeks, it will have completed the construction activities here.

Green Organic Dutchman Holdings is optimistic it will get the financing that it requires. In that particular regard, it will channel the funds towards accelerating its commercial production. The goal is to increase its revenues by a significant margin.

So far, the company has gotten into several supply agreements. Some of them are with Alberta, British Columbia, and Ontario. The deal is to engage in the distribution of products on a nationwide scale.

Continue Reading

Business

HEXO (OTCMKTS:HYYWF) Expects To Post Net Revenues Of $16.5 Million in Q4 2019 And $48.5 Million For FY 2019

Published

on

HEXO (OTCMKTS:HYYWF) expects to post net revenues of up to $16.5 million in Q4 2019. The company is hoping to post revenues of up to $48.5 million for FY 2019. It has withdrawn the previously announced outlook for FY 2020.

Q4 results below the estimates

Co-founder and Chief Executive Officer of Hexo, Sebastien St-Louis, said the net revenues of Q4 missed the forecast mainly because of reduced sales. He said the company is not happy with the results and will change operational and sales strategies to boost sales in the future.

The company is engaged in re-configuring the operations in the last quarter and would focus on high selling strains. Hexo began a new sales strategy to improve performance in the coming quarters.

Withdraws outlook for FY2020

A delay in getting the nod from government departments for the products extracted from cannabis together with store rollouts at a slower pace and pricing pressures are felt nationwide. A sluggish opening of retail stores has limited the reach of Hexo to significant customers in the market. It also sees an unpredictability to ensure the availability of cannabis-derived products because of delays in jurisdictional decisions and uncertainty in regulatory approvals in Canada. Therefore, Hexo decided to remove the previously announced forecast for FY 2020.

CEO said it is painful to withdraw the outlook for FY 2020. The company decided to withdraw the outlook because of the prevailing uncertainties in the market. Hexo is evaluating its operations and plans to improve efficiencies and achieve profitability. The company is focusing on strategic priorities to offer rich dividends to the shareholders in the long-term.

Hagens Berman alerts investors

Hagens Berman warned investors of an investigation into Hexo on violation of security laws. The firm informed investors to file a loss-form to find out if they qualify to recoup investment losses they have suffered in Hexo. The investigation team will check whether Hexo has misled the investors by exaggerating about its business model and the sales of cannabis products through the retailers.

Chief Finance Officer of Hexo, who joined the company a few months back, resigned abruptly. Following the exit of CFO, Christopher Carey, an analyst at Bank of America, has downgraded the stock to underperform.

Continue Reading

Business

LeafBuyer Technologies Inc. (OTCMKT:LBUY) Reports 59% YoY Growth In Revenue Following Optimization Of Its Platforms

Published

on

By

LeafBuyer Technologies Inc. (OTCMKT:LBUY) has announced that its annual revenue for FY 2019 grew by 59%, reflecting the revenue booked this year against last year. This growth is above the industry average that currently stands at 24%.

Leafbuyer optimized platforms to be competitive

Kurt Rosner, the CEO of Leafbuyer, stated that they had spent the year optimizing their platforms to have the edge over competitors. He added that they were determined to provide unrivaled tech solutions for the fast-growing cannabis industry. Rossner said that the sales team has continued to execute the company’s strategy, and it is maintaining the momentum as fall approaches.

Over the past year, the company greatly expanded its reach to several states, including Oklahoma and California, among others. Thus has allowed the Leafbuyer to reach a wider audience and enabled targeted sales initiatives. In June this year, the company opened a satellite office in Los Angeles, which provided a centralized and reachable hub for the company’s West Coast customers. The Los Angeles office has sufficient staff to allow the Denver based sales representatives to focus on selling in the East Coast and Midwest regions.

Leafbuyer has expanded its marketing platform

Besides conventional online listing, the company has also enhanced its marketing platform, and now it includes texting as well as loyalty products. The CEO said loyalty had been the company’s fastest-growing segment, and they are optimistic that it will maintain that growth momentum going to 2020.

In August, the company stated that it is in a path to profitability, and that will achieve its goal in the first half of next year. The company’s aggressive growth strategy focuses on user acquisition, and they hope to double its organic growth by the end of this year. The company’s management team is expecting some acquisitions with robust synergies going forward. The company recently acquired Greenlight Technologies, which is an application development company based in California. Currents the management is in negotiations for the acquisition of CBD.io, a Las Vegas-based trade show.

Continue Reading
Advertisement

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Trade


FEATURED STORIES

Business22 hours ago

Green Organic Dutchman Holdings (OTCMKTS:TGODF) To Review Financing Alternatives For Construction Purposes

Post Views: 111 Green Organic Dutchman Holdings (OTCMKTS:TGODF) has, over the years, been focusing on the production of premium organic...

Business22 hours ago

HEXO (OTCMKTS:HYYWF) Expects To Post Net Revenues Of $16.5 Million in Q4 2019 And $48.5 Million For FY 2019

Post Views: 107 HEXO (OTCMKTS:HYYWF) expects to post net revenues of up to $16.5 million in Q4 2019. The company...

Business4 days ago

LeafBuyer Technologies Inc. (OTCMKT:LBUY) Reports 59% YoY Growth In Revenue Following Optimization Of Its Platforms

Post Views: 204 LeafBuyer Technologies Inc. (OTCMKT:LBUY) has announced that its annual revenue for FY 2019 grew by 59%, reflecting...

Business4 days ago

High Tide Inc. (OTCMKTS:HITIF) Report Impressive Q3 Financial Results with Revenue Growing 281%

Post Views: 168 High Tide Inc. (OTCMKTS:HITIF) has announced an inspiring financial result for its third quarter of 2019. The...

Business5 days ago

Kalytera Therapeutics Inc (OTCMKTS:KALTF) Provides Details About Its Latest Notice Of Allowance

Post Views: 148 Kalytera Therapeutics Inc (OTCMKTS:KALTF) has today revealed details regarding the EU Patent Application Number 14791611.8. According to...

Business5 days ago

Pharmacyte Biotech Inc (OTCMKTS:PMCB) Engages Cellular Biologist David A. Judd In An Interview

Post Views: 752 Pharmacyte Biotech Inc (OTCMKTS:PMCB) uses its live-cell encapsulation technology known as Cell-in-a-Box®  for the treatment of diabetes...

Business6 days ago

CV Sciences Inc (OTCMKTS:CVSI) enters a Distribution Agreement With Harris Teeter

Post Views: 141 CV Sciences Inc (OTCMKTS:CVSI) today announced its business collaboration with Harris Teeter. These two business giants target...

Business6 days ago

Tetra Bio Pharma Inc (OTCMKTS:TBPMF) Speaks Out On Its CAUMZ(TM) Kit

Post Views: 158 Tetra Bio Pharma Inc (OTCMKTS:TBPMF) is one of the leaders in the cannabinoid-based therapeutics sector. Some of...

Business7 days ago

Medical Marijuana Inc (OTCMKTS:MJNA) Speaks Out On The European Road To Area Tour

Post Views: 178 Medical Marijuana Inc (OTCMKTS:MJNA) made a mark by becoming the first company to unveil cannabis-derived nutraceutical products....

Business7 days ago

HempAmericana Inc (OTCMKTS:HMPQ) To Unveil Its New Smokable Hemp Flower Product Line

Post Views: 156 HempAmericana Inc (OTCMKTS:HMPQ) will, on November 2019, unveil its new Smokable Hemp Flower product line. The company...

Whats Hot

CULTIVATING

SHAREHOLDER VALUE

 

Trading Symbol

CSE: CHOO
OTCQB: CHOOF

Choom Holdings Inc. CSE: CHOO | OTCQB: CHOOF